Update on Youth-Onset Type 2 Diabetes: Lessons Learned from the Treatment Options for Type 2 Diabetes in Adolescents and Youth Clinical Trial
Rachelle Gandica, Phil Zeitler, Rachelle Gandica, Phil Zeitler
No abstract availableKeywords: TODAY clinical trial; Type 2 diabetes; Update; Youth.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4955876/bin/nihms793098f1.jpg)
TODAY Primary Outcome Results (M= Metformin alone treatment arm; M+R= Metformin plus rosiglitazone treatment arm; M+L= Metformin plus intensive lifestyle changes treatment arm)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4955876/bin/nihms793098f2.jpg)
Primary Outcome Results Accordingly to Race, Ethnicity, Sex
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4955876/bin/nihms793098f3.jpg)
Distribution of Baseline HbA1c in Group 1 (no glycemic failure within 48 months) and Group 2 (glycemic failure within 48 months)
Source: PubMed